ALPHABIOTOXINE LABORATORY: what changed
ALPHABIOTOXINE LABORATORY
Largest movements
- Receivables within one year -€9,701
down €9,701 (-73.3%), from €13,237 to €3,536
of which Trade receivables: -€9,933
- Stocks and contracts +€5,730
up €5,730 (+53.4%), from €10,738 to €16,468
- Cash +€4,244
up €4,244 (+7.1%), from €59,921 to €64,165
mainly Receivables within one year (+€9,701) and Depreciation (+€4,560)
- Deferred charges and accrued income +€3,323
up €3,323 (+1,224%), from €271 to €3,594
- Tangible fixed assets -€1,951
down €1,951 (-7.9%), from €24,568 to €22,616
- Trade debts +€2,536
up €2,536, from €0 to €2,536
- Tax, wage and social debts -€2,252
down €2,252 (-46.1%), from €4,886 to €2,634
- Gross operating margin -€5,942
down €5,942 (-44.4%), from €13,371 to €7,429
- Other operating charges -€587
down €587 (-37.2%), from €1,580 to €993
- Financial charges +€431
up €431 (+71.0%), from €607 to €1,037
- Financial income -€154
down €154 (-40.6%), from €380 to €226
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €108,854 | €110,739 | +€1,884 | +1.7% |
| Fixed assets | 21/28 | €24,688 | €22,976 | -€1,711 | -6.9% |
| Tangible fixed assets | 22/27 | €24,568 | €22,616 | -€1,951 | -7.9% |
| Land and buildings | 22 | €4,756 | €3,956 | -€800 | -16.8% |
| Plant, machinery and equipment | 23 | €18,135 | €17,958 | -€177 | -1.0% |
| Furniture and vehicles | 24 | €1,677 | €703 | -€974 | -58.1% |
| Financial fixed assets | 28 | €120 | €360 | +€240 | +200% |
| Current assets | 29/58 | €84,167 | €87,762 | +€3,596 | +4.3% |
| Stocks and contracts in progress | 3 | €10,738 | €16,468 | +€5,730 | +53.4% |
| Stocks | 30/36 | €10,738 | €16,468 | +€5,730 | +53.4% |
| Amounts receivable within one year | 40/41 | €13,237 | €3,536 | -€9,701 | -73.3% |
| Trade receivables | 40 | €10,969 | €1,036 | -€9,933 | -90.6% |
| Other amounts receivable | 41 | €2,268 | €2,500 | +€232 | +10.2% |
| Cash at bank and in hand | 54/58 | €59,921 | €64,165 | +€4,244 | +7.1% |
| Deferred charges and accrued income | 490/1 | €271 | €3,594 | +€3,323 | +1,224% |
| Total equity and liabilities | 10/49 | €108,854 | €110,739 | +€1,884 | +1.7% |
| Equity | 10/15 | -€265 | €589 | +€854 | |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €303 | €303 | = | 0.0% |
| Distributable reserves | 133 | €303 | €303 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€19,168 | -€18,314 | +€854 | +4.5% |
| Amounts payable | 17/49 | €109,119 | €110,150 | +€1,030 | +0.9% |
| Amounts payable within one year | 42/48 | €109,119 | €110,150 | +€1,030 | +0.9% |
| Trade debts | 44 | €0 | €2,536 | +€2,536 | |
| Suppliers | 440/4 | €0 | €2,536 | +€2,536 | |
| Taxes, remuneration and social security | 45 | €4,886 | €2,634 | -€2,252 | -46.1% |
| Taxes | 450/3 | €4,886 | €2,634 | -€2,252 | -46.1% |
| Other amounts payable | 47/48 | €104,233 | €104,979 | +€746 | +0.7% |
| Remuneration, social security and pensions | 62 | €56 | - | -€56 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,538 | €4,560 | +€22 | +0.5% |
| Other operating charges | 640/8 | €1,580 | €993 | -€587 | -37.2% |
| Gross operating margin | 9900 | €13,371 | €7,429 | -€5,942 | -44.4% |
| Operating profit (loss) | 9901 | €7,196 | €1,877 | -€5,320 | -73.9% |
| Financial income | 75/76B | €380 | €226 | -€154 | -40.6% |
| Recurring financial income | 75 | €380 | €226 | -€154 | -40.6% |
| Financial charges | 65/66B | €607 | €1,037 | +€431 | +71.0% |
| Recurring financial charges | 65 | €607 | €1,037 | +€431 | +71.0% |
| Profit (loss) for the period before taxes | 9903 | €6,970 | €1,065 | -€5,904 | -84.7% |
| Income taxes | 67/77 | €233 | €211 | -€21 | -9.2% |
| Profit (loss) for the period | 9904 | €6,737 | €854 | -€5,883 | -87.3% |
| Profit (loss) for the period to be appropriated | 9905 | €6,737 | €854 | -€5,883 | -87.3% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.